Lupin Ltd’s stake sale in its Japanese subsidiary Kyowa Pharma has provided a dose of optimism to investors. The sale is expected to free-up capital that will...
Lupin Ltd reported an unanticipated quarterly loss after registering a one-time charge related to litigation over a blood pressure drug. Indian drugmaker created a provision...